GlassScriptPhysician profile
Marianne E Greene
NPI 1255340139
$898.02
in general payments reported to CMS, 2019-2025
16 companies · none reported in 2025
See the full distribution for Anatomic Pathology & Clinical Pathology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $138 · 2022: $19.61 · 2023: $406 · 2024: $334.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $740.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $740.36 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $169.24 | 2023-2024 | Enhertu, Tagrisso |
| Janssen Biotech, INC. | $153.44 | 2020-2023 | |
| Takeda Pharmaceuticals U.S.A., INC. | $111.66 | 2023-2024 | Fruzaqla, Ninlaro, Alunbrig |
| Daiichi Sankyo INC. | $66.85 | 2023-2024 | Enhertu |
| Seagen INC. | $60.61 | 2022-2023 | Tukysa |
| Beckman Coulter, INC. | $59.03 | 2023 | Dxa 5000 |
| Genentech USA, INC. | $49.35 | 2024 | Phesgo, Kadcyla, Perjeta |
| Incyte Corporation | $38.14 | 2023 | Jakafi |
| Regeneron Healthcare Solutions, INC. | $30.73 | 2024 | Libtayo |
| Axonics, INC. | $29.64 | 2020 | |
| Genzyme Corporation | $28.91 | 2023 | |
| Pfizer INC. | $24.05 | 2024 | |
| Novartis Pharmaceuticals Corporation | $23.55 | 2024 | |
| Puma Biotechnology, INC. | $19.60 | 2023 | |
| Agios Pharmaceuticals, INC. | $18.12 | 2023 | Pyrukynd |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alexion Pharmaceuticals, INC. | $15.10 | 2024 | Ultomiris |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marianne Greene listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.